![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: HDAC9 |
Gene summary for HDAC9 |
![]() |
Gene information | Species | Human | Gene symbol | HDAC9 | Gene ID | 9734 |
Gene name | histone deacetylase 9 | |
Gene Alias | HD7 | |
Cytomap | 7p21.1 | |
Gene Type | protein-coding | GO ID | GO:0000122 | UniProtAcc | Q9UKV0 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
9734 | HDAC9 | HTA11_3410_2000001011 | Human | Colorectum | AD | 3.38e-04 | 2.29e-01 | 0.0155 |
9734 | HDAC9 | HTA11_2487_2000001011 | Human | Colorectum | SER | 2.27e-12 | 4.99e-01 | -0.1808 |
9734 | HDAC9 | HTA11_1938_2000001011 | Human | Colorectum | AD | 8.82e-15 | 7.51e-01 | -0.0811 |
9734 | HDAC9 | HTA11_78_2000001011 | Human | Colorectum | AD | 2.14e-05 | 4.95e-01 | -0.1088 |
9734 | HDAC9 | HTA11_347_2000001011 | Human | Colorectum | AD | 1.87e-28 | 7.28e-01 | -0.1954 |
9734 | HDAC9 | HTA11_411_2000001011 | Human | Colorectum | SER | 8.88e-11 | 9.95e-01 | -0.2602 |
9734 | HDAC9 | HTA11_2112_2000001011 | Human | Colorectum | SER | 2.88e-10 | 1.40e+00 | -0.2196 |
9734 | HDAC9 | HTA11_3361_2000001011 | Human | Colorectum | AD | 1.29e-12 | 5.76e-01 | -0.1207 |
9734 | HDAC9 | HTA11_83_2000001011 | Human | Colorectum | SER | 1.97e-06 | 3.69e-01 | -0.1526 |
9734 | HDAC9 | HTA11_696_2000001011 | Human | Colorectum | AD | 9.88e-21 | 6.28e-01 | -0.1464 |
9734 | HDAC9 | HTA11_866_2000001011 | Human | Colorectum | AD | 1.53e-04 | 3.47e-01 | -0.1001 |
9734 | HDAC9 | HTA11_1391_2000001011 | Human | Colorectum | AD | 1.98e-11 | 5.66e-01 | -0.059 |
9734 | HDAC9 | HTA11_2992_2000001011 | Human | Colorectum | SER | 9.46e-03 | 3.27e-01 | -0.1706 |
9734 | HDAC9 | HTA11_5216_2000001011 | Human | Colorectum | SER | 4.34e-02 | 3.45e-01 | -0.1462 |
9734 | HDAC9 | HTA11_9341_2000001011 | Human | Colorectum | SER | 1.04e-03 | 4.74e-01 | -0.00410000000000005 |
9734 | HDAC9 | HTA11_7862_2000001011 | Human | Colorectum | AD | 1.49e-02 | 4.02e-01 | -0.0179 |
9734 | HDAC9 | HTA11_10623_2000001011 | Human | Colorectum | AD | 2.65e-12 | 9.15e-01 | -0.0177 |
9734 | HDAC9 | HTA11_7696_3000711011 | Human | Colorectum | AD | 2.51e-14 | 5.43e-01 | 0.0674 |
9734 | HDAC9 | HTA11_6818_2000001011 | Human | Colorectum | AD | 7.49e-27 | 1.63e+00 | 0.0112 |
9734 | HDAC9 | HTA11_11156_2000001011 | Human | Colorectum | AD | 1.25e-12 | 1.39e+00 | 0.0397 |
Page: 1 2 3 4 5 6 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:0032868 | Colorectum | AD | response to insulin | 91/3918 | 264/18723 | 2.02e-07 | 8.48e-06 | 91 |
GO:1901653 | Colorectum | AD | cellular response to peptide | 114/3918 | 359/18723 | 8.32e-07 | 2.88e-05 | 114 |
GO:0032869 | Colorectum | AD | cellular response to insulin stimulus | 72/3918 | 203/18723 | 1.10e-06 | 3.68e-05 | 72 |
GO:0071375 | Colorectum | AD | cellular response to peptide hormone stimulus | 95/3918 | 290/18723 | 1.50e-06 | 4.66e-05 | 95 |
GO:0043434 | Colorectum | AD | response to peptide hormone | 126/3918 | 414/18723 | 2.70e-06 | 7.86e-05 | 126 |
GO:0001667 | Colorectum | AD | ameboidal-type cell migration | 137/3918 | 475/18723 | 2.17e-05 | 4.33e-04 | 137 |
GO:0090132 | Colorectum | AD | epithelium migration | 105/3918 | 360/18723 | 1.18e-04 | 1.73e-03 | 105 |
GO:0010632 | Colorectum | AD | regulation of epithelial cell migration | 88/3918 | 292/18723 | 1.19e-04 | 1.75e-03 | 88 |
GO:0010631 | Colorectum | AD | epithelial cell migration | 104/3918 | 357/18723 | 1.33e-04 | 1.90e-03 | 104 |
GO:0090130 | Colorectum | AD | tissue migration | 105/3918 | 365/18723 | 2.10e-04 | 2.77e-03 | 105 |
GO:0010634 | Colorectum | AD | positive regulation of epithelial cell migration | 56/3918 | 176/18723 | 4.51e-04 | 5.03e-03 | 56 |
GO:0043542 | Colorectum | AD | endothelial cell migration | 78/3918 | 279/18723 | 2.97e-03 | 2.22e-02 | 78 |
GO:0010595 | Colorectum | AD | positive regulation of endothelial cell migration | 40/3918 | 133/18723 | 8.01e-03 | 4.73e-02 | 40 |
GO:00328681 | Colorectum | SER | response to insulin | 65/2897 | 264/18723 | 6.70e-05 | 1.53e-03 | 65 |
GO:00016671 | Colorectum | SER | ameboidal-type cell migration | 105/2897 | 475/18723 | 6.97e-05 | 1.59e-03 | 105 |
GO:19016531 | Colorectum | SER | cellular response to peptide | 83/2897 | 359/18723 | 8.03e-05 | 1.77e-03 | 83 |
GO:00434341 | Colorectum | SER | response to peptide hormone | 93/2897 | 414/18723 | 9.61e-05 | 2.04e-03 | 93 |
GO:00901321 | Colorectum | SER | epithelium migration | 82/2897 | 360/18723 | 1.50e-04 | 2.93e-03 | 82 |
GO:00106311 | Colorectum | SER | epithelial cell migration | 81/2897 | 357/18723 | 1.87e-04 | 3.44e-03 | 81 |
GO:00713751 | Colorectum | SER | cellular response to peptide hormone stimulus | 68/2897 | 290/18723 | 2.20e-04 | 3.89e-03 | 68 |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa0520325 | Esophagus | ESCC | Viral carcinogenesis | 137/4205 | 204/8465 | 2.47e-07 | 1.88e-06 | 9.62e-07 | 137 |
hsa0520335 | Esophagus | ESCC | Viral carcinogenesis | 137/4205 | 204/8465 | 2.47e-07 | 1.88e-06 | 9.62e-07 | 137 |
hsa052034 | Lung | IAC | Viral carcinogenesis | 43/1053 | 204/8465 | 3.02e-04 | 3.07e-03 | 2.04e-03 | 43 |
hsa0520311 | Lung | IAC | Viral carcinogenesis | 43/1053 | 204/8465 | 3.02e-04 | 3.07e-03 | 2.04e-03 | 43 |
hsa052038 | Oral cavity | OSCC | Viral carcinogenesis | 124/3704 | 204/8465 | 5.57e-07 | 3.28e-06 | 1.67e-06 | 124 |
hsa0520314 | Oral cavity | OSCC | Viral carcinogenesis | 124/3704 | 204/8465 | 5.57e-07 | 3.28e-06 | 1.67e-06 | 124 |
hsa0520342 | Oral cavity | EOLP | Viral carcinogenesis | 55/1218 | 204/8465 | 1.54e-06 | 1.34e-05 | 7.92e-06 | 55 |
hsa0520351 | Oral cavity | EOLP | Viral carcinogenesis | 55/1218 | 204/8465 | 1.54e-06 | 1.34e-05 | 7.92e-06 | 55 |
hsa0520361 | Oral cavity | NEOLP | Viral carcinogenesis | 56/1112 | 204/8465 | 2.90e-08 | 5.34e-07 | 3.36e-07 | 56 |
hsa0520371 | Oral cavity | NEOLP | Viral carcinogenesis | 56/1112 | 204/8465 | 2.90e-08 | 5.34e-07 | 3.36e-07 | 56 |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
HDAC9 | SNV | Missense_Mutation | novel | c.364N>T | p.Arg122Cys | p.R122C | Q9UKV0 | protein_coding | deleterious(0) | possibly_damaging(0.809) | TCGA-85-8048-01 | Lung | lung squamous cell carcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
HDAC9 | SNV | Missense_Mutation | novel | c.1958A>T | p.Asn653Ile | p.N653I | Q9UKV0 | protein_coding | deleterious(0) | benign(0.262) | TCGA-85-8070-01 | Lung | lung squamous cell carcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
HDAC9 | SNV | Missense_Mutation | novel | c.2752N>A | p.Ala918Thr | p.A918T | Q9UKV0 | protein_coding | deleterious(0.03) | probably_damaging(0.996) | TCGA-85-A4QR-01 | Lung | lung squamous cell carcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
HDAC9 | SNV | Missense_Mutation | novel | c.1925N>T | p.Pro642Leu | p.P642L | Q9UKV0 | protein_coding | deleterious(0) | benign(0.04) | TCGA-90-A4ED-01 | Lung | lung squamous cell carcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
HDAC9 | SNV | Missense_Mutation | novel | c.2824N>A | p.Gln942Lys | p.Q942K | Q9UKV0 | protein_coding | deleterious(0.01) | benign(0.163) | TCGA-90-A59Q-01 | Lung | lung squamous cell carcinoma | Female | <65 | I/II | Chemotherapy | cisplatin | PD |
HDAC9 | SNV | Missense_Mutation | novel | c.484N>C | p.Asp162His | p.D162H | Q9UKV0 | protein_coding | tolerated(0.06) | possibly_damaging(0.884) | TCGA-98-8022-01 | Lung | lung squamous cell carcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
HDAC9 | SNV | Missense_Mutation | novel | c.2371N>T | p.Thr791Ser | p.T791S | Q9UKV0 | protein_coding | tolerated(0.12) | benign(0.013) | TCGA-NC-A5HM-01 | Lung | lung squamous cell carcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
HDAC9 | SNV | Missense_Mutation | novel | c.1895N>A | p.Pro632His | p.P632H | Q9UKV0 | protein_coding | tolerated(0.61) | benign(0.001) | TCGA-O2-A52Q-01 | Lung | lung squamous cell carcinoma | Female | <65 | III/IV | Unknown | Unknown | PD |
HDAC9 | insertion | Frame_Shift_Ins | novel | c.2348_2349insT | p.Gly784TrpfsTer5 | p.G784Wfs*5 | Q9UKV0 | protein_coding | TCGA-35-4123-01 | Lung | lung adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD | ||
HDAC9 | deletion | Frame_Shift_Del | c.1260delC | p.Leu421TyrfsTer29 | p.L421Yfs*29 | Q9UKV0 | protein_coding | TCGA-64-5781-01 | Lung | lung adenocarcinoma | Female | <65 | I/II | Chemotherapy | cisplatin | PD |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
9734 | HDAC9 | TRANSCRIPTION FACTOR BINDING, TRANSCRIPTION FACTOR COMPLEX, ENZYME, TRANSCRIPTION FACTOR, DRUGGABLE GENOME | inhibitor | SB939 | ||
9734 | HDAC9 | TRANSCRIPTION FACTOR BINDING, TRANSCRIPTION FACTOR COMPLEX, ENZYME, TRANSCRIPTION FACTOR, DRUGGABLE GENOME | inhibitor | PCI-24781 | ABEXINOSTAT | |
9734 | HDAC9 | TRANSCRIPTION FACTOR BINDING, TRANSCRIPTION FACTOR COMPLEX, ENZYME, TRANSCRIPTION FACTOR, DRUGGABLE GENOME | inhibitor | 310264675 | CUDC-101 | |
9734 | HDAC9 | TRANSCRIPTION FACTOR BINDING, TRANSCRIPTION FACTOR COMPLEX, ENZYME, TRANSCRIPTION FACTOR, DRUGGABLE GENOME | MOCETINOSTAT | MOCETINOSTAT | 23829483,26287310 | |
9734 | HDAC9 | TRANSCRIPTION FACTOR BINDING, TRANSCRIPTION FACTOR COMPLEX, ENZYME, TRANSCRIPTION FACTOR, DRUGGABLE GENOME | BUTYRYLHYDROXAMIC ACID | BUTYRYLHYDROXAMIC ACID | 21874153 | |
9734 | HDAC9 | TRANSCRIPTION FACTOR BINDING, TRANSCRIPTION FACTOR COMPLEX, ENZYME, TRANSCRIPTION FACTOR, DRUGGABLE GENOME | inhibitor | ROMIDEPSIN | ROMIDEPSIN | |
9734 | HDAC9 | TRANSCRIPTION FACTOR BINDING, TRANSCRIPTION FACTOR COMPLEX, ENZYME, TRANSCRIPTION FACTOR, DRUGGABLE GENOME | PMID29671355-Compound-25 | |||
9734 | HDAC9 | TRANSCRIPTION FACTOR BINDING, TRANSCRIPTION FACTOR COMPLEX, ENZYME, TRANSCRIPTION FACTOR, DRUGGABLE GENOME | SUBEROHYDROXAMIC ACID | SUBEROHYDROXAMIC ACID | 16921367 | |
9734 | HDAC9 | TRANSCRIPTION FACTOR BINDING, TRANSCRIPTION FACTOR COMPLEX, ENZYME, TRANSCRIPTION FACTOR, DRUGGABLE GENOME | inhibitor | CUDC-101 | CUDC-101 | |
9734 | HDAC9 | TRANSCRIPTION FACTOR BINDING, TRANSCRIPTION FACTOR COMPLEX, ENZYME, TRANSCRIPTION FACTOR, DRUGGABLE GENOME | VORINOSTAT | VORINOSTAT |
Page: 1 2 3 4 5 6 7 |